This competitive renewal application requests continued support for the General Clinical Research Center (GCRC) at Yale University School of Medicine and Yale-New Haven Medical Center. Request is made for support of personnel, physical facilities and laboratory and computer resources to provide Yale faculty with the necessary resources to conduct patient-oriented research. These resources include: a seven-bed inpatient unit; outpatient facilities; a core laboratory; a Nutrition Unit (i.e. a metabolic kitchen); a biostatistician and a data processing unit. Yale faculty in the School of Medicine, Nursing and Arts & Science will conduct research in multiple areas in interests, but primary emphasis is directed toward diabetes and carbohydrate metabolism, bone disease and calcium metabolism, and the neurosciences including both drug abuse and Parkinson's disease. New initiatives are planned for gene therapy and the molecular genetics of hypertension. Funds for renovation and modernization of the out-patient facilities are requested. The results of both therapeutic studies and an increased understanding of the mechanisms of human disease processes will result in improved human health. This GCRC also serves as an extremely valuable resource in the training of both future clinical investigators and practitioners.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000125-37
Application #
6078242
Study Section
General Clinical Research Centers Committee (CLR)
Program Officer
Sogn, Dorothy D
Project Start
1978-12-01
Project End
2001-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
37
Fiscal Year
2000
Total Cost
$2,688,678
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Kelsey, Megan M; Braffett, Barbara H; Geffner, Mitchell E et al. (2018) Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. J Clin Endocrinol Metab 103:2309-2318
Kleinberger, Jeffrey W; Copeland, Kenneth C; Gandica, Rachelle G et al. (2018) Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med 20:583-590
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
Kriska, Andrea; El Ghormli, Laure; Copeland, Kenneth C et al. (2018) Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes. Pediatr Diabetes 19:36-44
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Venditti, E M; Tan, K; Chang, N et al. (2018) Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes. Diabetes Res Clin Pract 139:24-31
Gidding, Samuel S; Bacha, Fida; Bjornstad, Petter et al. (2018) Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr 192:86-92.e5
Arslanian, Silva; El Ghormli, Laure; Bacha, Fida et al. (2017) Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care 40:85-93
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Krystal, John H (2016) Neuroethology as a translational neuroscience strategy in the era of the NIMH Research Domain Criteria. Psychophysiology 53:364-6

Showing the most recent 10 out of 343 publications